肝炎，乙型；血清标志物；模式；复检。
对tia患者早期诊断的血清标志物：mind - tia协议的研究。
Serum biomarkers for the early diagnosis of TIA: the MIND-TIA study protocol.
探讨孕中期母血清标志物及脐动脉血流用于预测不良妊娠结局的临床价值。
To investigate the clinical value of second trimester maternal serum screening and umbilical artery Doppler for prediction of adverse pregnancy outcome.
根据服药史、临床表现、肝功能、血清标志物及停药后的治疗效果综合判断。
The analysis was based on drugtaking history, clinical manifestations, liver function, serum markers and response after drug withdrawal.
目的：探讨乙型肝炎病毒DNA定量与肝炎临床的转归及血清标志物的关系。
Objective:To investigate the relationship among serum HBV DNA quantification, hepatitis clinical changes and HBV markers in hepatitis patients.
然而，在拉米夫定的治疗过程中，并没有有效的血清标志物能预测变异的早期发生。
However, there is no useful serum marker that can predict early emergence of mutants during LAM therapy.
孕中期母血清标志物升高合并脐动脉血流异常者，发生不良妊娠结局的风险升高。
High levels of maternal serum markers combine with abnormal umbilical index are associated with higher adverse outcome incidence.
结论：ND- 1对人结肠癌患者血清具有较好的特异性，是具有应用价值的新型血清标志物。
Conclusions: nd 1 has a good specificity to the serodiagnosis of colorectal cancer patients and is a new serum mark that has value of application.
杀死动物，从脊椎、股骨和胫骨取松质骨标本，进行显微ct扫描及力学测试，并监测血清标志物。
After killing the animals, cancellous bone specimens from the vertebra, femurs, and tibias were micro-CT scanned and tested mechanically. Serum biomarkers were determined.
目的：通过药物抑制乙肝病毒血清标志物(HBV - M)的实验，观察药物抑制HBV的作用。
Objective: To investigate the effect of anti-HBV drugs using the experiment of anti-HBV-M.
与母血清标志物升高有关的不良结局有子痫前期、新生儿窒息、胎儿生长受限、胎儿丢失及胎盘异常。
The high levels of maternal serum markers was significantly associated with preeclampsia, neonatal asphyxia, fetal growth restriction, fetal demise, and abnormal placenta.
目的探讨定量检测乙型肝炎病毒血清标志物（HBVM）与（HBVDNA）定量之间的关系及临床意义。
Objective To explore the clinical significance and the relationship between the HBV DNA quantity and the quantity testing of HBVM.
在过去的十年中，肝纤维化进展相关的血清标志物研究取得了很大的进展，为肝纤维化的无创诊断带来了新希望。
Thus it is necessary to seek ideal non-invasive method. Last decade's breakthroughs of serum markers brought new hope to the diagnosis.
结论乙型肝炎肝硬化患者肝移植后预防乙型肝炎复发应采用HBVDNA、YMDD变异及血清标志物联合检测。
Conclusion the combination detection of YMDD variants, HBV DNA and HBV serum markers may define HBV reinfection after liver transplantation in the patients with hepatitis b.
结论TRFIA技术检测HBV血清标志物灵敏度高、特异性强，可替代MEIA和ELISA而成为一种常规检测方法。
Conclusion To detect HBV markers in serum, TRFIA offers many benefits in sensitivity, specificity, accuracy and practicability, and may be a routine method instead of MEIA and ELISA.
方法用酶联免疫吸附试验对982例乙肝患者血清标志物和乙肝病毒前S2抗原进行检测；并用荧光定量PCR法对其进行HBV-DNA检测。
Methods Hepatitis B serum markers and Pre-S2 antigens were tested by enzyme-linked immunosorbent assay and HBV DNA was detected by fluorescent quantitative-PCR in 982 hepatitis B patients.
在ra病程中，血清的形态学和再吸收标志物浓度的改变指示出随着疾病的进程，骨代谢活力降低。
Serum morphogenesis and resorption markers' concentrations change in course of ra indicating the decrease in bone metabolic activity with the disease duration and progression.
血管内皮功能障碍可以通过一系列生物标志物：血清内皮素- 1,e -选择素和mmp—9水平的提高来评估。
Endothelial dysfunction can be measured by the increased levels of a set of biomarkers, such as serum endothelin-1, E-Selectin and MMP-9.
服用维生素d的患者，内皮功能障碍的生物标志物如：血清内皮素1、E -选择和MMP - 9，水平也较低。
The biomarkers of endothelial dysfunction, serum endothelin-1, E-Selectin and MMP-9, levels were also lower for the patients taking vitamin d.
观察治疗8周后大鼠的相关血清酶类、肝纤维化标志物、氧自由基及肝组织病理学等变化。
The changes of related serum enzymes, liver-fibrosis marker, oxygen free radical and liver tissue pathology were observed after 8 weeks of treatment.
结论合理利用血清肿瘤标志物检查肺癌患者，既有助于诊断，又可做到合理检查、避免资源浪费。
Utilizing serum tumor markers reasonably to detect lung cancer patients was not only better for diagnose, but also for reasonable detection and avoiding wasting resources.
目的构建预测慢性肝炎肝脏炎症和纤维化程度的数学模型，评价血清纤维化标志物的应用价值。
Objective to build mathematical models for diagnosing liver inflammation and fibrosis degrees in chronic hepatitis, and to revaluate the value of serum fibrotic markers in clinical practice.
方法：观察治疗组及对照组治疗前、后血清肝纤维化标志物、肝功能的变化。
METHODS:The change of serum liver fibrosis markers and hepatic function were observed in treatment group and control group before and after treatment.
熟悉鞍区畸胎瘤的影像学特点，全面的组织病理学检查、血清及脑脊液肿瘤标志物检测是诊断和治疗的重要依据。
To be familiar with the characteristics of image, comprehensive histopathologic examination combined with serum and CSF tumors markers detection were necessary for correct diagnosis and treatment.
目的：评价血清肿瘤标志物CA15 - 3在乳腺癌中的临床应用价值。
Objective:To evaluate the clinical significance of serum tumor marker CA15-3 in patients with breast cancer.
血清肿瘤标志物联合检测可提高诊断肺癌敏感性。
The sensitivity of lung cancer diagnosis is raised by combined assay with serum tumor marker.
SELDI蛋白质芯片技术能直接筛选出肺腺癌患者血清中相对特异的潜在标志物，具有较好的临床应用价值。
SELDI-TOF-MS proteinchip technology can screen out relatively specific, potential markers from serum of lung adenocarcinoma patients, so it has better clinical value.
应用反向间接血凝试验（RPHA）、酶免疫测定（EIA）和聚合酶链反应（PCR）测定了家禽血清、卵黄和牛乳清中HBV标志物及人HBV-DNA。
The HBV markers and HBV DNA in poultry sera, Yolk and bovine milk whey were detected by reversed passive hemagglutination assay (RPHA), enzyme immunoassay (EIA) and polymerase chain reaction (PCR).
目的探讨乙型肝炎（下称乙肝）病毒DNA（HBV-DNA）与血清免疫标志物的关系。
Objective To explore the relationship between HBV-DNA and HBV immune markers in serum.
目的探讨乙型肝炎（下称乙肝）病毒DNA（HBV-DNA）与血清免疫标志物的关系。
Objective To explore the relationship between HBV-DNA and HBV immune markers in serum.
应用推荐